Status of Metastatic Bladder Cancer Treatment Illustrated by a Case.
Bladder cancer
Guidelines
Treatment
Journal
Seminars in oncology nursing
ISSN: 1878-3449
Titre abrégé: Semin Oncol Nurs
Pays: United States
ID NLM: 8504688
Informations de publication
Date de publication:
02 2021
02 2021
Historique:
pubmed:
11
1
2021
medline:
23
11
2021
entrez:
10
1
2021
Statut:
ppublish
Résumé
This study aims to provide an overview of current treatment guidelines within the context of metastatic bladder cancer illustrated by a case report. International guidelines from The American Society of Clinical Oncology (ASCO), The European Society of Medical Oncology (ESMO), and scientific references supporting these clinical guidelines. To illustrate the implementation of current evidence-based guidelines a patient case report was presented. Historically, there have been limited treatment options available for metastatic bladder cancer for three decades. However, with the introduction of immunotherapy and emergent targeted therapies for metastatic bladder cancer increasing survival rates are expected. To achieve improved treatment outcome in people affected by metastatic bladder cancer it is important that both doctors and nurses are aware of contemporary evidence-based treatment options in keeping with ESMO and ASCO international clinical guidelines. Nurses play an important role in educating patients about the potential side effects of therapy and in offering timely, tailored, and supported self-management.
Identifiants
pubmed: 33422366
pii: S0749-2081(20)30128-5
doi: 10.1016/j.soncn.2020.151113
pii:
doi:
Types de publication
Case Reports
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
151113Informations de copyright
Copyright © 2020 Elsevier Inc. All rights reserved.